(2)Commission Implementing Regulation (EU) 2017/1115note renewed the approval of propoxycarbazone as an active substance, however, not as a candidate for substitution. Indeed, the new assessment did not confirm the persistency of the substance, which lead to that substance no longer meeting two of the criteria to be considered as a PBT substance. It was therefore included in the Annex, part B, of Commission Implementing Regulation (EU) No 540/2011note.